Tongxin Zhihui

Founded in 2014, Tongxin Zhihui, leveraging its algorithms and technical capabilities, develops AI-based diagnosis and auxiliary diagnosis products for major brain diseases such as brain tumors, and has established a brain disease business product matrix that covers multiple disease types, scenarios, and cycles. Following the path of "R&D-Product-Application," Tongxin Zhihui has built three platforms: the product R&D platform "Tongxin Brain Science," the product transformation platform "Tongxin Gewu," and the product application platform "Tongxin Yilian," aiming to build a new generation of AI brain science diagnosis and treatment platform "Tongxin Zhihui." On the basis of technology and products, Tongxin Zhihui has built an online internet hospital plus offline medical institutions and an imaging center with a two-way interconnected product application platform "Tongxin Yilian" (the predecessor of "Tongxin Zhihui"), cooperating with a large number of hospitals to explore the needs of clinical doctors, equipping them with corresponding AI auxiliary products, and while products are effectively applied, accumulating substantial resources and application feedback to feed back into technology and product iteration. Team background: The company was founded by returnees from well-known foreign universities. The entrepreneurial team has worked together for many years, and the core team consists of mobile healthcare compound talents from Stanford University, Tsinghua University, Peking University, and other well-known domestic and foreign universities, with years of background and experience in medical informatization, hospital management, and medical investment in the healthcare field. Tsinghua platform: As one of the initiators of the Tsinghua University Neo Healthcare Alliance ("Tsinghua New Medical Alliance"), Tongxin Yilian aims to unite people of vision in Chinese healthcare to explore how to use new technologies to establish a brand-new patient-centered medical and health development model. At the same time, the Tsinghua Neo Healthcare Alliance provides Tongxin Yilian with a high-end platform for academic marketing and resource aggregation, and is also one of Tongxin Yilian's important strategic partners. Corporate culture: User first, proactive, achieve team, innovative and change-seeking, open and candid. Mission: To make life journeys less painful and more dignified. Vision: Brain science artificial intelligence technology medical platform. Company honors and awards: 1. On October 10, 2014, received the Beijing Overseas Students Entrepreneurship Funding Certificate issued by the Beijing Overseas Talents Center; 2. On November 13, 2014, received the Zhongguancun Golden Seed Enterprise certification from the Administrative Committee of Zhongguancun Science Park; 3. On April 17, 2015, received the 2015 Beijing Overseas Returnees Entrepreneurship Start-up Support Fund issued by the Beijing Municipal Human Resources and Social Security Bureau; 4. In 2015, received the Lenovo Star Medal from the Lenovo College of the Chinese Academy of Sciences; 5. In 2015, received the 2015 Zhongguancun Third Batch Young Eagle Talent Entrepreneurship Special Fund issued by the Zhongguancun Administrative Committee; 6. In 2015, the CEO of Tongxin Yilian was awarded the "Annual Outstanding Column Writer" by the healthcare industry internet new media "Health Point"; 7. In February 2016, received the 2015 Zhongguancun Top Ten Venture Capital Cases (co-investment by Junlian and Jingwei to boost Tongxin Yilian in promoting innovation in the medical field) issued by the Zhongguancun Social Organization Federation; 8. In June 2016, received the 2016 SME Promotion Special Innovation Project Funding from the Beijing Municipal Science and Technology Commission; 9. In July 2016, received the Zhongguancun High-tech Enterprise certification approved by the Administrative Committee of Zhongguancun Science Park.